Fmr LLC Sells 28,600 Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Fmr LLC cut its holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) by 3.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 917,700 shares of the biopharmaceutical company’s stock after selling 28,600 shares during the period. Fmr LLC owned about 1.83% of Corbus Pharmaceuticals Holdings worth $5,782,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Evanson Asset Management LLC grew its stake in shares of Corbus Pharmaceuticals Holdings by 1.5% in the second quarter. Evanson Asset Management LLC now owns 20,660 shares of the biopharmaceutical company’s stock valued at $130,000 after buying an additional 300 shares in the last quarter. Capital Fund Management S.A. bought a new position in shares of Corbus Pharmaceuticals Holdings in the second quarter valued at $130,000. SG Americas Securities LLC bought a new position in shares of Corbus Pharmaceuticals Holdings in the first quarter valued at $148,000. Credit Suisse AG bought a new position in shares of Corbus Pharmaceuticals Holdings in the first quarter valued at $157,000. Finally, Nationwide Fund Advisors bought a new position in shares of Corbus Pharmaceuticals Holdings in the second quarter valued at $158,000. Institutional investors own 31.77% of the company’s stock.

Several equities analysts recently weighed in on CRBP shares. BidaskClub raised shares of Corbus Pharmaceuticals Holdings from a “sell” rating to a “hold” rating in a research note on Saturday, July 8th. Cantor Fitzgerald set a $24.00 target price on shares of Corbus Pharmaceuticals Holdings and gave the company a “buy” rating in a research note on Monday, July 17th. Noble Financial reissued a “buy” rating on shares of Corbus Pharmaceuticals Holdings in a research note on Wednesday, August 9th. Finally, ValuEngine cut shares of Corbus Pharmaceuticals Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, September 13th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $19.75.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) opened at $6.90 on Friday.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) last issued its quarterly earnings data on Wednesday, August 9th. The biopharmaceutical company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.04. Corbus Pharmaceuticals Holdings had a negative net margin of 1,001.77% and a negative return on equity of 107.10%. The firm had revenue of $0.35 million for the quarter, compared to analyst estimates of $0.50 million. equities research analysts forecast that Corbus Pharmaceuticals Holdings, Inc. will post -0.63 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Fmr LLC Sells 28,600 Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP)” was published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.com-unik.info/2017/11/04/fmr-llc-sells-28600-shares-of-corbus-pharmaceuticals-holdings-inc-crbp.html.

Corbus Pharmaceuticals Holdings Profile

Corbus Pharmaceuticals Holdings, Inc is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment.

Want to see what other hedge funds are holding CRBP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP).

Institutional Ownership by Quarter for Corbus Pharmaceuticals Holdings (NASDAQ:CRBP)

What are top analysts saying about Corbus Pharmaceuticals Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Corbus Pharmaceuticals Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit